S

Shanghai Universal Biotech Co Ltd
SZSE:301166

Watchlist Manager
Shanghai Universal Biotech Co Ltd
SZSE:301166
Watchlist
Price: 31.8 CNY 1.6% Market Closed
Market Cap: ¥2.8B

Shanghai Universal Biotech Co Ltd
Investor Relations

Shanghai Universal Biotech Co Ltd is a CN-based company operating in Health Care Providers & Services industry. The company is headquartered in Shanghai, Shanghai and currently employs 493 full-time employees. The company went IPO on 2021-12-28. Shanghai Universal Biotech Co Ltd is a China-based company mainly engaged in the supply of life science reagent products. The firm is also engaged in the supply of life science instruments and consumables and comprehensive technical services. The products supplied by the Company are mainly third-party brand products, supplemented by independent brand products. The life science reagents mainly include immunological reagents based on antibodies and antibody related reagents, as well as molecular biology reagents, cell biology reagents and biochemical reagents. The life science instruments and consumables include detection and analysis and sample preparation. The comprehensive technical services include experimental services, technical support services and other services.

Show more
Loading
301166
Shanghai Composite
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Zhaowu Leng
Chairman & GM
No Bio Available
Ms. Min Tang
CFO & Deputy GM
No Bio Available
Ms. Waying Chen
Deputy GM & Director
No Bio Available
Ms. Yanfang Qi
Board Secretary, Deputy GM & Director
No Bio Available
Mr. Bo Wang
Deputy General Manager
No Bio Available

Contacts

Address
SHANGHAI
Shanghai
Room 1505, No.1690, Kongjiang Road, Yangpu District
Contacts
+862138939000
www.univ-bio.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett